[go: up one dir, main page]

GB201111378D0 - Use of prodrugs to avoid GI medicated adverse events - Google Patents

Use of prodrugs to avoid GI medicated adverse events

Info

Publication number
GB201111378D0
GB201111378D0 GBGB1111378.4A GB201111378A GB201111378D0 GB 201111378 D0 GB201111378 D0 GB 201111378D0 GB 201111378 A GB201111378 A GB 201111378A GB 201111378 D0 GB201111378 D0 GB 201111378D0
Authority
GB
United Kingdom
Prior art keywords
medicated
prodrugs
avoid
adverse events
adverse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1111378.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shire LLC
Original Assignee
Shire LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire LLC filed Critical Shire LLC
Priority to GBGB1111378.4A priority Critical patent/GB201111378D0/en
Publication of GB201111378D0 publication Critical patent/GB201111378D0/en
Priority to US13/253,677 priority patent/US20120202756A1/en
Priority to PCT/GB2011/051911 priority patent/WO2012046062A1/en
Ceased legal-status Critical Current

Links

GBGB1111378.4A 2009-04-02 2011-07-04 Use of prodrugs to avoid GI medicated adverse events Ceased GB201111378D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB1111378.4A GB201111378D0 (en) 2011-07-04 2011-07-04 Use of prodrugs to avoid GI medicated adverse events
US13/253,677 US20120202756A1 (en) 2009-04-02 2011-10-05 Use of prodrugs to avoid gi mediated adverse events
PCT/GB2011/051911 WO2012046062A1 (en) 2010-10-05 2011-10-05 Use of prodrugs to avoid gi mediated adverse events

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1111378.4A GB201111378D0 (en) 2011-07-04 2011-07-04 Use of prodrugs to avoid GI medicated adverse events

Publications (1)

Publication Number Publication Date
GB201111378D0 true GB201111378D0 (en) 2011-08-17

Family

ID=44512050

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1111378.4A Ceased GB201111378D0 (en) 2009-04-02 2011-07-04 Use of prodrugs to avoid GI medicated adverse events

Country Status (1)

Country Link
GB (1) GB201111378D0 (en)

Similar Documents

Publication Publication Date Title
IL255045A0 (en) Crystal of flumioxazin
EP2712362A4 (en) Manufacture of lacto-n-tetraose
GB201104096D0 (en) Production of graphene
EP2521545A4 (en) Prodrugs of heteraromatic compounds
SG11201402112RA (en) Use of humanized mice to determine toxicity
PL2753330T3 (en) Therapeutic uses of ectoin
CO6791617A2 (en) Combinations of active compounds
PL2666014T3 (en) Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles
EP2756418A4 (en) Distributing events to large numbers of devices
GB201104001D0 (en) Improvements to goggles
ZA201307229B (en) Prodrugs of d-isoglutamyl-[d/l]- tryprophan
IL230977A (en) Crystalline form of rilapladib
CO6821942A2 (en) Combinations of active compounds
IL259184B (en) Crystal of flumioxazin
ZA201307230B (en) Prodrugs of d-gamma-glutamyl-d-tryptophan and d-gamma-glutamyl-l-tryptophan
GB201211721D0 (en) Improvements is or relating to urolgical catheters
EP2726505A4 (en) THERAPEUTIC TARGETING OF FICOLIN-3
GB201111378D0 (en) Use of prodrugs to avoid GI medicated adverse events
GB201111382D0 (en) Use of prodrugs to avoid GI medicated adverse events
GB201016752D0 (en) Use of prodrugs to avoid gi mediated adverse events
IL231452A (en) Amorphous form of dolutegravir
GB201116297D0 (en) Structure configured to produce an optical effect
GB201111388D0 (en) Prodrugs of pramipexole and related compounds
GB201104632D0 (en) Use of medicament
GB201204590D0 (en) Prodrugs of thiazolamine compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)